SEQENS
Yaarit Dror is an experienced professional in the pharmaceutical and API sectors, currently serving as FDF Business Manager at SEQENS since February 2023. Dror also holds the position of Regional Sales Director at Wavelength Pharmaceuticals and Wavelength Enterprise Ltd. since November 2017, overseeing sales in Germany, Austria, Switzerland, and Central and Eastern Europe for API and FDF products. Previously, Dror worked at ChemAgis, an API Division of Perrigo, from January 2013 to November 2017, also as Regional Sales Director, and held various roles at ChemAgis from 2003 to 2013, including Project Manager and Europe Desk Manager. Academically, Dror earned a Bachelor of Laws in Commercial Law from the College of Law and Business (2020-2023), an MBA from The Open University Israel (2014-2018), and a BA in Human Behavior, Management, and Economics from Ben-Gurion University of the Negev (2000-2002).
This person is not in any offices
SEQENS
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.4 MM€ and operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. 3,400 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.